Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 9 studies | 28% ± 7% | |
CD8-positive, alpha-beta T cell | 8 studies | 25% ± 5% | |
mucosal invariant T cell | 7 studies | 22% ± 4% | |
T cell | 7 studies | 22% ± 7% | |
CD4-positive, alpha-beta T cell | 5 studies | 21% ± 6% | |
exhausted T cell | 4 studies | 23% ± 6% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 25% ± 8% | |
CD4-positive helper T cell | 3 studies | 24% ± 4% | |
gamma-delta T cell | 3 studies | 19% ± 3% | |
CD4-positive, alpha-beta cytotoxic T cell | 3 studies | 25% ± 4% |
Insufficient scRNA-seq data for expression of CXCR6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 323.60 | 576 / 578 | 84% | 6.76 | 971 / 1155 |
stomach | 98% | 227.77 | 352 / 359 | 72% | 5.42 | 207 / 286 |
intestine | 93% | 217.63 | 898 / 966 | 70% | 4.23 | 369 / 527 |
uterus | 96% | 90.39 | 164 / 170 | 66% | 5.57 | 301 / 459 |
bladder | 90% | 143.05 | 19 / 21 | 57% | 3.88 | 289 / 504 |
thymus | 98% | 157.05 | 642 / 653 | 49% | 3.15 | 295 / 605 |
esophagus | 82% | 85.86 | 1192 / 1445 | 59% | 3.37 | 108 / 183 |
prostate | 96% | 113.91 | 236 / 245 | 43% | 1.80 | 214 / 502 |
breast | 77% | 68.92 | 352 / 459 | 60% | 3.91 | 667 / 1118 |
skin | 70% | 50.04 | 1271 / 1809 | 57% | 6.01 | 267 / 472 |
pancreas | 66% | 38.55 | 216 / 328 | 60% | 4.20 | 106 / 178 |
ovary | 89% | 71.07 | 161 / 180 | 34% | 1.54 | 145 / 430 |
kidney | 60% | 61.22 | 53 / 89 | 62% | 4.45 | 562 / 901 |
liver | 81% | 54.97 | 184 / 226 | 32% | 1.80 | 128 / 406 |
spleen | 100% | 1160.39 | 241 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 33.47 | 28 / 29 |
peripheral blood | 92% | 229.66 | 851 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 12.69 | 41 / 45 |
blood vessel | 89% | 92.39 | 1188 / 1335 | 0% | 0 | 0 / 0 |
muscle | 88% | 369.68 | 709 / 803 | 0% | 0 | 0 / 0 |
adipose | 85% | 100.47 | 1022 / 1204 | 0% | 0 | 0 / 0 |
heart | 76% | 65.15 | 655 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 68% | 41.85 | 176 / 258 | 7% | 0.28 | 17 / 230 |
brain | 6% | 3.52 | 169 / 2642 | 7% | 0.29 | 48 / 705 |
eye | 0% | 0 | 0 / 0 | 13% | 0.84 | 10 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0006954 | Biological process | inflammatory response |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0019079 | Biological process | viral genome replication |
GO_0060326 | Biological process | cell chemotaxis |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016493 | Molecular function | C-C chemokine receptor activity |
GO_0019957 | Molecular function | C-C chemokine binding |
GO_0015026 | Molecular function | coreceptor activity |
GO_0016494 | Molecular function | C-X-C chemokine receptor activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
Gene name | CXCR6 |
Protein name | C-X-C chemokine receptor type 6 (CXC-R6) (CXCR-6) (CDw186) (G-protein coupled receptor STRL33) (G-protein coupled receptor bonzo) (CD antigen CD186) C-X-C chemokine receptor type 6 (G-protein coupled receptor bonzo) |
Synonyms | STRL33 BONZO hCG_15326 TYMSTR |
Description | FUNCTION: Receptor for the C-X-C chemokine CXCL16. Used as a coreceptor by SIVs and by strains of HIV-2 and m-tropic HIV-1. FUNCTION: Receptor for the C-X-C chemokine CXCL16. Used as a coreceptor by SIVs and by strains of HIV-2 and m-tropic HIV-1. . |
Accessions | ENST00000438735.1 ENST00000458629.1 ENST00000457814.1 ENST00000304552.5 A0N0N3 O00574 |